Commonwealth Equity Services
TGTX icon

Commonwealth Equity Services’s TG Therapeutics TGTX Stock Holding History

Commonwealth Equity Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Buy
186,987
+6,702
+4% +$274K 0.01% 925
2026
Q1 		$5.99M Sell
180,285
-1,716
-0.9% -$51.1K 0.01% 1219
2025
Q4 		$5.43M Sell
182,001
-4,710
-3% -$154K 0.01% 1259
2025
Q3 		$6.75M Buy
186,711
+14,408
+8% +$475K 0.01% 1139
2025
Q2 		$6.2M Sell
172,303
-3,465
-2% -$129K 0.01% 1176
2025
Q1 		$6.93M Sell
175,768
-13,344
-7% -$449K 0.01% 1076
2024
Q4 		$5.69M Sell
189,112
-8,925
-5% -$256K 0.01% 1160
2024
Q3 		$4.63M Buy
198,037
+11,043
+6% +$241K 0.01% 1268
2024
Q2 		$3.33M Buy
186,994
+2,360
+1% +$37.7K 0.01% 1453
2024
Q1 		$2.81M Buy
184,634
+124
+0.1% +$1.98K ﹤0.01% 1540
2023
Q4 		$3.15M Buy
184,510
+2,110
+1% +$24.5K 0.01% 1395
2023
Q3 		$1.52M Buy
182,400
+29,878
+20% +$417K ﹤0.01% 1791
2023
Q2 		$3.79M Sell
152,522
-2,695
-2% -$69.6K 0.01% 1210
2023
Q1 		$2.33M Buy
155,217
+13,007
+9% +$198K ﹤0.01% 1470
2022
Q4 		$1.68M Buy
142,210
+22,946
+19% +$167K ﹤0.01% 1616
2022
Q3 		$706K Buy
119,264
+7,525
+7% +$49.4K ﹤0.01% 2146
2022
Q2 		$474K Buy
111,739
+97,391
+679% +$608K ﹤0.01% 2447
2022
Q1 		$136K Buy
14,348
+4,270
+42% +$49.4K ﹤0.01% 3426
2021
Q4 		$191K Sell
10,078
-1,574
-14% -$40.9K ﹤0.01% 3319
2021
Q3 		$387K Buy
11,652
+5,596
+92% +$173K ﹤0.01% 2678
2021
Q2 		$234K Buy
+6,056
New +$238K ﹤0.01% 3132

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Commonwealth Equity Services's TGTX Position: Q2 2026 in Review

Commonwealth Equity Services increased its TG Therapeutics (TGTX) stake by 3.7% in Q2 2026, buying an estimated $274K and bringing the position to 186,987 shares worth $10.3M. The position accounts for 0.01% of the portfolio, ranked #925.

Commonwealth Equity Services first reported a position in TGTX in Q2 2021 and has held it in 21 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Commonwealth Equity Services held 186,987 shares of TG Therapeutics worth $10.3M as of Q2 2026.
  • Commonwealth Equity Services bought 6,702 TG Therapeutics shares in Q2 2026, an estimated $274K.
  • TG Therapeutics made up 0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #925 holding.
  • Commonwealth Equity Services first reported a position in TG Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.